Chemomab Therapeutics Ltd. Accounts Payable and Other Accrued Liabilities, Current
Chemomab Therapeutics Ltd. (CMMB) had Accounts Payable and Other Accrued Liabilities, Current of $1.73 million as of 2020-12-31, per its 10-K filed 2021-03-09.
Discontinued › Notes › Payables and Accruals
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2021-03-09
- 2020-12-31: Accounts Payable and Other Accrued Liabilities, Current $1.73M.
- 2020-09-30: Accounts Payable and Other Accrued Liabilities, Current $1.62M.
- 2020-06-30: Accounts Payable and Other Accrued Liabilities, Current $609.00K.
- 2020-03-31: Accounts Payable and Other Accrued Liabilities, Current $2.68M.
| Period end | Accounts Payable and Other Accrued Liabilities, Current |
|---|---|
| 2020-12-31 | $1.73M 10-K · filed 2021-03-09 |
| 2020-09-30 | $1.62M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $609.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $2.68M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $2.85M 10-K · filed 2021-03-09 |